Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Developmental Cell|June 20, 2018
EMT Subtype Influences Epithelial Plasticity and Mode of Cell MigrationNicole M Aiello, Ravikanth Maddipati, Robert J Norgard, et al.
Journal for Immunotherapy of Cancer|July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V Long, Hao Tang, Keyur Desai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.
Scientific Reports|March 24, 2018
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clustersNeha Bhagwat, Keely Dulmage, Charles H Pletcher, et al.
NPJ Precision Oncology|June 6, 2022
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcomeRuiwen Ding, Prateek Prasanna, Germán Corredor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung CancerMark M Awad, Patrick M Forde, Nicolas Girard, et al.
NPJ Precision Oncology|June 1, 2023
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancerCristian Barrera, Germán Corredor, Vidya Sankar Viswanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNAJeffrey C Thompson, Stephanie S Yee, Andrea B Troxel, et al.
Nature Medicine|October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancerJulie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung CancerHossein Borghaei, David Balli, Luis G Paz-Ares, et al.
Pageof 3